0001209191-23-016316.txt : 20230306
0001209191-23-016316.hdr.sgml : 20230306
20230306164216
ACCESSION NUMBER: 0001209191-23-016316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASADORIAN RAFFI
CENTRAL INDEX KEY: 0001628970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 23709482
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25821 INDUSTRIAL BOULEVARD
STREET 2: SUITE 400
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 25821 INDUSTRIAL BOULEVARD
STREET 2: SUITE 400
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-03
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001628970
ASADORIAN RAFFI
C/O ACELRX PHARMACEUTICALS, INC.
25821 INDUSTRIAL BLVD., SUITE 400
HAYWARD
CA
94545
0
1
0
0
Chief Financial Officer
Common Stock
2023-03-03
4
F
0
510
1.31
D
22081
D
Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
/s/ Martha Adler, Attorney-In-Fact
2023-03-06